Cargando…
Inhibition of Abl Kinase by Imatinib Can Rescue the Compromised Barrier Function of 22q11.2DS Patient-iPSC-Derived Blood–Brain Barriers
We have previously established that the integrity of the induced blood–brain barrier (iBBB) formed by brain microvascular endothelial cells derived from the iPSC of 22q11.2 DS (22q11.2 Deletion Syndrome, also called DiGeorge Syndrome) patients is compromised. We tested the possibility that the haplo...
Autores principales: | Li, Yunfei, Sun, Zhixiong, Zhu, Huixiang, Sun, Yan, Shteyman, David B., Markx, Sander, Leong, Kam W., Xu, Bin, Fu, Bingmei M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913366/ https://www.ncbi.nlm.nih.gov/pubmed/36766762 http://dx.doi.org/10.3390/cells12030422 |
Ejemplares similares
-
Investigation of Neurodevelopmental Deficits of 22 q11.2 Deletion Syndrome with a Patient-iPSC-Derived Blood–Brain Barrier Model
por: Li, Yunfei, et al.
Publicado: (2021) -
Human iPSC banking: barriers and opportunities
por: Huang, Ching-Ying, et al.
Publicado: (2019) -
Excess α-synuclein compromises phagocytosis in iPSC-derived macrophages
por: Haenseler, Walther, et al.
Publicado: (2017) -
Role of iPSC-derived pericytes on barrier function of iPSC-derived brain microvascular endothelial cells in 2D and 3D
por: Jamieson, John J., et al.
Publicado: (2019) -
Recent advances in human iPSC-derived models of the blood–brain barrier
por: Workman, Michael J., et al.
Publicado: (2020)